Myelodysplastic Syndromes (MDS): Diagnosis, Risk Stratification, and Evidence-Based Management for the Practicing Hematologist/Oncologist
Introduction and Pathophysiology Myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic stem cell disorders characterized by: Ineffective hematopoiesis, leading to persistent peripheral blood cytopenias (anemia, neutropenia, thrombocytopenia), Dysplasia…
